Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Feb 11:11:34.
doi: 10.1186/1741-7015-11-34.

Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders

Emanuel Severus  1 , Michael Bauer
Affiliations
Editorial

Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders

Emanuel Severus et al. BMC Med. .

Abstract

Lithium has been the most effective psychopharmacological drug in the long-term treatment of patients with recurrent unipolar and bipolar affective illness. As a result of its widespread and longtime use in patients with recurrent affective disorders, psychiatrists have become increasingly aware of the whole spectrum of lithium's potential side effects. One of the side effects associated with its chronic use is lithium-induced nephropathy. In a recent cross-sectional study published in BMC Medicine, Alberto Bocchetta et al. add further information to this topic, demonstrating that duration of lithium treatment is associated with impaired glomerular function in patients with recurrent or chronic affective disorders. The present paper will discuss the implications of this and other related recent research on our management of patients with recurrent affective disorders. In this context the importance of shared decision making and close monitoring of kidney function is highlighted, including the regular assessment of the glomerular filtration rate, to provide best possible care to our patients maintained on lithium treatment.See related research article here http://www.biomedcentral.com/1741-7015/11/33.

PubMed Disclaimer

Comment on

References

    1. Pfennig A, Bschor T, Baghai T, Braunig P, Brieger P, Falkai P, Geissler D, Gielen R, Giesler H, Gruber O, Kopp I, Meyer TD, Mohrmann KH, Muche-Borowski C, Padberg F, Scherk H, Strech D, Bauer M. [S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations] Nervenarzt. 2012;83:568–586. doi: 10.1007/s00115-011-3415-3. Article in German. - DOI - PubMed
    1. Grunfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5:270–276. doi: 10.1038/nrneph.2009.43. - DOI - PubMed
    1. Bocchetta A, Ardau R, Carta P, Ligas F, Sardu C, Pani A, Del Zompo M. Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med. 2013;11:33. doi: 10.1186/1741-7015-11-33. - DOI - PMC - PubMed
    1. Bassilios N, Martel P, Godard V, Froissart M, Grunfeld JP, Stengel B. Monitoring of glomerular filtration rate in lithium-treated outpatients--an ambulatory laboratory database surveillance. Nephrol Dial Transplant. 2008;23:562–565. - PubMed
    1. Tredget J, Kirov A, Kirov G. Effects of chronic lithium treatment on renal function. J Affect Disord. 2010;126:436–440. doi: 10.1016/j.jad.2010.04.018. - DOI - PubMed

MeSH terms

LinkOut - more resources